NO883806L - Fremgangsmaate til omdannelse av en polymorf krystallinsk form til en annen. - Google Patents

Fremgangsmaate til omdannelse av en polymorf krystallinsk form til en annen.

Info

Publication number
NO883806L
NO883806L NO88883806A NO883806A NO883806L NO 883806 L NO883806 L NO 883806L NO 88883806 A NO88883806 A NO 88883806A NO 883806 A NO883806 A NO 883806A NO 883806 L NO883806 L NO 883806L
Authority
NO
Norway
Prior art keywords
polymorph
converting
procedure
another
crystallinic
Prior art date
Application number
NO88883806A
Other languages
English (en)
Other versions
NO169284C (no
NO169284B (no
NO883806D0 (no
Inventor
Robert James Behme
Terry Tim Kensler
Douglas Gene Mikolasek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO883806D0 publication Critical patent/NO883806D0/no
Publication of NO883806L publication Critical patent/NO883806L/no
Publication of NO169284B publication Critical patent/NO169284B/no
Publication of NO169284C publication Critical patent/NO169284C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Gears, Cams (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Arrangement Or Mounting Of Propulsion Units For Vehicles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Body Structure For Vehicles (AREA)
NO883806A 1987-08-28 1988-08-25 Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form NO169284C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/090,302 US4810789A (en) 1987-08-28 1987-08-28 Process for buspirone hydrochloride polymorphic crystalline form conversion

Publications (4)

Publication Number Publication Date
NO883806D0 NO883806D0 (no) 1988-08-25
NO883806L true NO883806L (no) 1989-03-01
NO169284B NO169284B (no) 1992-02-24
NO169284C NO169284C (no) 1992-06-03

Family

ID=22222189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883806A NO169284C (no) 1987-08-28 1988-08-25 Fremgangsmaate for omdannelse av en polymorf krystallinsk form av buspiron-hydroklorid til dens andre polymorfe krystallinske form

Country Status (23)

Country Link
US (1) US4810789A (no)
EP (1) EP0304940B1 (no)
JP (1) JP2702519B2 (no)
KR (1) KR970011294B1 (no)
AT (1) ATE113044T1 (no)
AU (1) AU618746B2 (no)
CY (1) CY1839A (no)
DE (1) DE3851865T2 (no)
DK (1) DK478688A (no)
ES (1) ES2060632T3 (no)
FI (1) FI91066C (no)
HK (1) HK71495A (no)
HU (1) HU199831B (no)
IE (1) IE65988B1 (no)
IL (1) IL87292A (no)
MY (1) MY100863A (no)
NO (1) NO169284C (no)
NZ (1) NZ225895A (no)
OA (1) OA08907A (no)
PT (1) PT88355B (no)
SU (1) SU1731056A3 (no)
YU (1) YU46961B (no)
ZA (1) ZA885867B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
HU217129B (hu) * 1993-07-16 1999-11-29 EGIS Gyógyszergyár Rt. Eljárás nagy tisztaságú buspiron gyógyászati hatóanyag előállítására
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
KR100322018B1 (ko) * 1999-01-23 2002-02-04 윤종용 음성대역 잡음 보상장치
US6465255B1 (en) * 1999-01-29 2002-10-15 The Regents Of The University Of California Method for identifying and probing phase transitions in materials
US7612095B2 (en) * 2002-04-19 2009-11-03 Faes Farma, S.A. Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4351939A (en) * 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone

Also Published As

Publication number Publication date
ZA885867B (en) 1989-05-30
HU199831B (en) 1990-03-28
DE3851865T2 (de) 1995-02-23
SU1731056A3 (ru) 1992-04-30
AU2048088A (en) 1989-03-02
HK71495A (en) 1995-05-19
YU46961B (sh) 1994-09-09
JP2702519B2 (ja) 1998-01-21
IL87292A (en) 1992-07-15
US4810789A (en) 1989-03-07
KR890003739A (ko) 1989-04-17
OA08907A (en) 1989-10-31
AU618746B2 (en) 1992-01-09
NO169284C (no) 1992-06-03
DK478688A (da) 1989-03-01
IE882362L (en) 1989-02-28
NO169284B (no) 1992-02-24
FI91066C (fi) 1994-05-10
DE3851865D1 (de) 1994-11-24
IE65988B1 (en) 1995-11-29
ES2060632T3 (es) 1994-12-01
DK478688D0 (da) 1988-08-26
EP0304940A1 (en) 1989-03-01
PT88355A (pt) 1989-06-30
KR970011294B1 (ko) 1997-07-09
YU160488A (en) 1990-04-30
PT88355B (pt) 1995-12-29
MY100863A (en) 1991-03-15
NO883806D0 (no) 1988-08-25
CY1839A (en) 1995-12-01
FI91066B (fi) 1994-01-31
EP0304940B1 (en) 1994-10-19
FI883960A0 (fi) 1988-08-26
IL87292A0 (en) 1989-01-31
ATE113044T1 (de) 1994-11-15
JPS6471872A (en) 1989-03-16
FI883960A (fi) 1989-03-01
HUT47563A (en) 1989-03-28
NZ225895A (en) 1991-04-26

Similar Documents

Publication Publication Date Title
PL266567A1 (en) A method of crystalline acid hydrates 7-2-/2-aminotiazolil-4/4-carboxylobutene-2-oiloamino-3-cefemocarboxyl-4 production
IE870134L (en) 1, 4-dihydropyridines
NO168475C (no) Fremgangsmaate for fremstilling av kinolin-3-karboksylsyre-forbindelser.
NO883806D0 (no) Fremgangsmaate til omdannelse av en polymorf krystallinsk form til en annen.
EP0282037A3 (en) Process for preparing high purity polycrystalline silicon
SE8501679L (sv) Stereokontrollerat acetoxiazetidinon-forfarande
HUT43992A (en) Process for production of crystalline metall-gluconates
PL268034A1 (en) The method of manufacture of new 7-phenylglycil-1-carbo-destiacephalosphorines
HUT37444A (en) Process for preparing bestatin derivatives
EP0154225A3 (en) Process for the preparation of an optically active lactone, and intermediates in the process
FR2570069B1 (fr) Procede de synthese d'un aluminosilicate cristallin
SE8603458L (sv) Omvandling av polykarboxylsyror till polyoler
DE3262771D1 (en) Process for the preparation of tetronic acid
JPS5543053A (en) Preparation of optically active gamma-hydroxyundecanoic acid
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
DE3572965D1 (en) Process for the production of optically active quinone derivatives
DK521785D0 (da) Fremgangsmaade til fremstilling af halogenerede 3,3-dimethyl-5-hexan-2-oner
IL68207A0 (en) Production of 1,2,5,6-tetrahydro-4h-pyrrolo(3,2,1-ij)quinoline-4-one and 5-halo-1,2,3-(1,2-dihydropyrrolo)-4-quinolines used as intermediates therefor
FR2592873A1 (fr) Nouveau derive monophosphazene, procede d'obtention et application
ES2003642A6 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina
ES8604515A1 (es) Procedimiento para la obtencion del acido (4r,5r)-1,4,5,6- tetrahidro-5-hidroxi-4-((e)-(3s)-3-hidroxi-1-octenil)-1-fe- nilciclopenta (b)pirrollo-2-valerico